Inventor
KU YI-YIN
US30 patents
⚠️ This page may combine multiple inventors who share the name “KU YI-YIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
18 patentsUS6437106B1Aug 20, 2002
Process for preparing 6-o-substituted erythromycin derivatives
ABBOTT LAB161 citations96
US7153889B2Dec 26, 2006
Bicyclic-substituted amines as histamine-3 receptor ligands
ABBOTT LAB18 citations92
US7094790B2Aug 22, 2006
Fused bicyclic-substituted amines as histamine-3 receptor ligands
ABBOTT LAB19 citations92
US5864023AJan 26, 1999
3'-N'oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
ABBOTT LAB46 citations92
US5837829ANov 17, 1998
9-oximesilyl erythromycin a derivatives
ABBOTT LAB35 citations92
US5892008AApr 6, 1999
Process for the preparation of 6-O-methyl erythromycin a using 9-hydroxy erythromycin derivatives
ABBOTT LAB46 citations90
US5719272AFeb 17, 1998
2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives
ABBOTT LAB48 citations90
US7358263B2Apr 15, 2008
Fused bicyclic-substituted amines as histamine-3 receptor ligands
ABBOTT LAB11 citations83
US7807697B2Oct 5, 2010
Fused bicyclic-substituted amines as histamine-3 receptor ligands
ABBOTT LAB2 citations62
US7244852B2Jul 17, 2007
Process for preparing 2-methylpyrrolidine and specific enantiomers thereof
ABBOTT LAB5 citations62
US6822101B2Nov 23, 2004
Process for preparing amine-substituted benzofurans
ABBOTT LAB2 citations61
US6518430B1Feb 11, 2003
Process for the preparation of 5-(substituted)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-chromeno[3,4-F]quinolines and derivatives thereof
ABBOTT LAB2 citations59
US5562831AOct 8, 1996
Method for separation of gibberellin mixtures
ABBOTT LAB5 citations57
US7947711B2May 24, 2011
Bicyclic-substituted amines as histamine-3 receptor ligands
ABBOTT LAB0 citations51
US7932245B2Apr 26, 2011
Spirocyclopropyl amides and acids and their therapeutic applications
ABBOTT LAB1 citations51
US7145005B2Dec 5, 2006
2-(6-{2-[(2R)-2-Methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyridazin-3-one salts and their preparation
ABBOTT LAB1 citations50
US5580989ADec 3, 1996
Process for the preparation of N-4-[(substituted phenyl)alkylheterocyclic]-N
ABBOTT LAB0 citations48
US6608216B2Aug 19, 2003
Process for the preparation of chiral glucocorticoid receptor agents
ABBOTT LAB0 citations40
ABBVIE INC
6 patentsUS10053474B2Aug 21, 2018
Anti-viral compounds
ABBVIE INC0 citations48
US9676797B2Jun 13, 2017
Anti-viral compounds
ABBVIE INC1 citations48
US9199992B2Dec 1, 2015
Processes for the preparation of an apoptosis-inducing agent
ABBVIE INC0 citations48
US9006438B2Apr 14, 2015
Processes for the preparation of an apoptosis-inducing agent
ABBVIE INC1 citations48
US9238652B2Jan 19, 2016
Processes for the preparation of an apoptosis-inducing agent
ABBVIE INC0 citations46
US9227901B2Jan 5, 2016
Process for preparing bicyclic amine derivatives
ABBVIE INC0 citations34